Cite
HARVARD Citation
Lala, M. et al. (2020). A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation. European journal of cancer. pp. 68-75. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lala, M. et al. (2020). A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation. European journal of cancer. pp. 68-75. [Online].